Protection after yellow fever vaccination in patients using medication suppressing the immune system.
- Conditions
- yellow fever vaccination
- Registration Number
- NL-OMON20476
- Lead Sponsor
- Academic Medical Center, Amsterdam, the Netherlands
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
1. Age > 18 years;
2. YF 17D vaccination administered.
Exclusion Criteria
1. Age < 18 years;
2. Vaccination administered > 20 years ago.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of those with CD8 positive T cells in the group using immunosuppressive medication versus healthy controls.
- Secondary Outcome Measures
Name Time Method Proportion of those with Virus Neutralising antibody present in the group using immunosuppressive medication versus healthy controls.<br /><br>Proportion of those with local adverse events n the group using immunosuppressive medication versus healthy controls.